Suscríbase para recibir boletines informativos y actualizaciones ocasionales sobre nuestros últimos proyectos y servicios.
(Ginsheim/Gräfelfing) This month, the listed company PharmaSGP is transferring the warehousing, order picking and dispatch of selected branded products such as Spalt or Formigran to the logistics service provider Movianto, who specialises in the pharmaceutical and healthcare sectors. PharmaSGP, based in Gräfelfing near Munich, focuses on the development and distribution of non-prescription branded products. For quality assurance reasons, PharmaSGP has committed to full temperature control of the medicines it distributes.
“We are pleased that PharmaSGP has decided to work with us in the future, relying completely on active temperature control,” says Dennis Spamer, Managing Director of Movianto Germany. “Not only warehousing, but also dispatch to pharmacies and wholesalers is actively temperature-controlled at 15 to 25 degrees. This is still not standard for non-prescription OTC products.” According to Spamer, temperature control is playing an increasingly important role in the logistics of pharmaceuticals, but also increasingly of medical products. “We are experiencing steadily increasing demand for this and will further expand our capacity in this area next year.”
PharmaSGP is a leading consumer health company with a diversified portfolio of non-prescription OTC medicines and other health products marketed with a focus on the pharmacy distribution channel. The majority of the company’s medicines are based on natural active pharmaceutical ingredients with documented efficacy and few known side effects. The company’s core brands cover chronic indications, including rheumatic pain and nerve pain, as well as other age-related conditions. In Germany, PharmaSGP is the market leader in systemic, chemical-free analgesics with its RubaXX® family of brands for rheumatic pain and Restaxil® for neuralgic pain. In addition, PharmaSGP offers leading products for sexual weakness and vertigo. Since the launch of the first product from the current product portfolio in 2012, PharmaSGP has successfully established its business model in other European countries, including Austria, Italy, Belgium, Spain and France. In September 2021, the product portfolio was expanded to include the brands Baldriparan®, Formigran®, Spalt® and Kamol®, thus further expanding or developing the indication areas of pain and sleep disorders. In the 2021 financial year, PharmaSGP generated sales revenues of 65.3 million euros. www.pharmasgp.com
Movianto is part of the Walden Group, founded in 1951. With its one-stop-shop service for the distribution of healthcare products, Walden is now Europe’s market leader for logistics and transport in the pharmaceutical and healthcare industry. Movianto aims to be the preferred European logistics partner for this industry and to offer the best service for pharmaceutical as well as biotechnical products, for medical technology as well as for diagnostics. Along the logistics chain of such products, Movianto as an outsourcing partner offers, for example, warehouse logistics and transport (also temperature-controlled), but also complete solutions such as order to cash or purchasing and procurement services. Movianto’s international clients benefit from a pan-European network, a wide range of pharmaceutical logistics, unique industry know-how and standardised processes in accordance with quality standards such as ISO 9001 and ISO 13485. Movianto employs more than 3,200 people, has space for more than 630,000 pallets in its network of 23 company-owned logistics centres in eleven European countries and operates throughout Europe.
Walden is a family-owned group of companies consisting of six different operating companies with two different areas of expertise: express transport and healthcare/pharmaceuticals. Walden has 70 years of experience in the healthcare field and is today Europe’s market leader with its own logistics centres in 12 countries, more than 6,000 employees and a turnover of 2.1 billion euros in 2022. The group is today led by Stéphane Baudry, the grandson of the founder. With numerous investments, Walden has developed, among other things, digital solutions to increase the safety and quality of its subsidiaries’ processes. The company is committed to the values of integrity, quality and innovation in the service of healthcare.
Laure Murat | Marketing and Communication at Walden Group
Movianto was approached by a leading medical technology company that needed to upgrade their separate Czech and Slovak logistics solutions i...
30th March 2023
A global pharmaceutical manufacturer was experiencing supply chain issues due to the coronavirus. Movianto found a solution based on repacka...
28th March 2023
Theramex needed help importing their products into Europe from the UK and the rest of the world. Movianto stepped in to help them.
14th February 2023
Having continuously committed to environmental care and an ethical way of doing business, Movianto in Germany and in Switzerland is proud to...
24th January 2023
Condiciones de uso Aviso de Privacidad